Moran Kyle 4
4 · Wave Life Sciences Ltd. · Filed Feb 6, 2025
Insider Transaction Report
Form 4
Moran Kyle
Chief Financial Officer
Transactions
- Award
Share Option (right to buy)
2025-02-04+252,000→ 252,000 totalExercise: $11.74Exp: 2035-02-04→ Ordinary Shares (252,000 underlying) - Award
Ordinary Shares
2025-02-04+42,000→ 89,218 total
Footnotes (3)
- [F1]Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on February 8, 2026 through February 8, 2029.
- [F2]Includes 2,441 ordinary shares acquired on January 14, 2025, under the issuer's 2019 Employee Share Purchase Plan.
- [F3]The option vests as to 25% of the shares on February 8, 2026, and vests as to an additional 6.25% of the shares quarterly thereafter until February 8, 2029.